【正文】 Other (Please specify..) 9. Now, please indicate all the reasons why you selected one of the pharmaceutical panies as your least preferred employer. (Select all that apply) Not as strong in benefits Not as many career paths available Lower pensation than in the other panies Culture at pany is not as appealing Not as much diversity in the workforce Ethics amp。 Scientific Research Community Survey We value your opinions. As an important member of the scientific research munity, we invite you to answer a few questions concerning trends in the scientific munity. This is a market research study. Your answers are confidential. No one is selling or offering any products or services. In appreciation of your assistance, the first 100 people who plete this survey will receive a $50 dining card from . the list below, please indicate the categories that best apply to your participation in the scientific research munity. (Multiple selections available) Scientific Research Student (BS/MS, MD, PhD, MD, PhD/MD, post DOC Fellow) Professor, Assistant/Associate Professor in the scientific research field An academic leadership position specializing in the scientific research field Research Scientist working for a government agency A government agency leadership position managing scientific research Research Scientist for a business or an organization A business/organization leadership position managing the scientific research I am not involved in the scientific research field Another profession in the scientific research munity [Specify] Other (Please specify..) 2. Please indicate your area(s) of expertise. Biochemistry Bioinformatics Cancer Research Cell Biology Clinical Research Cytology Drug Discovery Genetics Genomics Immunology Microbiology Molecular Biology Neuroscience Pathology Protemics Virology Other (Please specify..) 3. If you are a student, please indicate the university below. 4. Please indicate the name of the business, organization, agency, or university where you work. 5. How many years have you been working in the Scientific Research field? I am still a student (have not yet worked in the field) Less than 1 year 1 year to 3 years 4 years to 5 years 6 years to 10 years 11 years to 15 years 16 years to 20 years 21 or more years 6. Which statement best reflects your interest in finding a job? (Please select one statement) At this time I am not looking for a job I am keeping my eyes open to new job opportunities I am actively looking for a new job and contacting panies, schools, organizations, and/or agencies 7. The following is a list of pharmaceutical panies. Assuming you were interested in finding a new job opportunity, which pharmaceutical pany would be your employer of choice? Please rank each of these pharmaceutical panies in order of your preference. Use a scale of 1 to 10 where ??means that the pharmaceutical pany is your most preferred employer. Your second most preferred employer would be assigned a ?.?Your third most preferred employer would be assigned a ?? up to ?0?which would be your least preferred employer. Amgen 1 = most preferred employer 2 3 4 5 6 7 8 9 10=least preferred employer AstraZeneca 1 = most preferred employer 2 3 4 5 6 7 8 9 10=least preferred employer BristolMyers Squibb 1 = most preferred employer 2 3 4 5 6 7 8 9 10=least preferred employer GlaxoSmith Kline 1 = most preferred employer 2 3 4 5 6 7 8 9 10=least preferred employer Johnsonamp。另據(jù)悉，結(jié)合百時美施貴寶公司依發(fā)韋侖（efavirenz，sustiva）和吉利德公司（gilead）truvada的抗艾滋病新藥已經(jīng)提交fda審批。降血脂藥普伐他?。╬ravastatin，普拉固，pravachol）銷售增長3%。abilify銷售增長51%?！　∪^產(chǎn)品plavix、抗艾滋病藥atazanavir sulfate（reyataz）、抗腫瘤藥西妥昔單抗（cetuximab，erbitux）和精神分裂癥治療藥阿立哌唑（aripiprazole，abilify）增長勢頭強勁。 　　本季度凈銷售增長3%，為47億美元。 　　百時美施貴寶公司：plavix銷售良好推動一季度收益增長 　　受到拳頭產(chǎn)品抗凝血藥氯吡格雷（clopidogrel，波立維，plavix）等銷售良好的推動作用，百時美施貴寶公司（bristolmyers squibb）2006年第一季度凈收益增長34%。據(jù)了解，阿斯利康已經(jīng)達成協(xié)議將與abraxis bioscience公司共同在美國推廣化療藥物紫杉醇納米制劑（paclitexal，abraxane）。據(jù)悉，之前，～。 　　基于第一季度的良好表現(xiàn)，阿斯利康上調(diào)了2006年全年收益，～。arimidex銷售收入增長38%。seroquel銷售收入增長29%。 　　五大拳頭產(chǎn)品的總銷售收入增長25%，包括抗?jié)兯幇Ｋ髅览颍╡someprazole，nexium）、精神分裂癥治療藥喹硫平（quetiapine fumarate，seroquel）、降膽固醇藥羅蘇伐他?。╮osuvastatin，crestor）、抗腫瘤藥阿那曲唑（anastrozole，瑞寧得，arimidex）和哮喘治療藥物復(fù)方平喘藥布地奈德+福莫特羅（budesonide+formoterol，symbicort）。營業(yè)利潤增長36%。 　　。 　　阿斯利康公司：一季度業(yè)績好于預(yù)期 　　受到拳頭產(chǎn)品銷售強勁的推動作用以及有效的成本節(jié)約措施，阿斯利康公司（astrazeneca）2006年第一季度業(yè)績好于預(yù)期。 　公司總裁表示，惠氏公司在2006年擁有了一個好的開始。prevnar銷售收入增長10%?！　】挂钟羲巈ffexor銷售收入增長9%。 　　。 　　 惠氏公司：文拉法新和肺炎疫苗銷售強勁推動一季度凈收益增長 　　受到拳頭產(chǎn)品肺炎多價疫苗（multivalent conjugate vaccine，prevnar）和抗抑郁藥文拉法新（venlafaxine，effexor）銷售強勁的推動作用，惠氏公司（wyeth）%。此外，默克也正準(zhǔn)備上市輪狀病毒疫苗rotateq。美國fda當(dāng)局將于6月8日做出審批決定。公司希望今年能上市宮頸癌疫苗gardasil。公司預(yù)計zocor今年銷售收入將